Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 242

1.

Rational use of generic psychotropic drugs.

Carbon M, Correll CU.

CNS Drugs. 2013 May;27(5):353-65. doi: 10.1007/s40263-013-0045-2. Review.

PMID:
23620145
[PubMed - indexed for MEDLINE]
2.

The bioequivalence and therapeutic efficacy of generic versus brand-name psychoactive drugs.

Borgheini G.

Clin Ther. 2003 Jun;25(6):1578-92. Review.

PMID:
12860486
[PubMed - indexed for MEDLINE]
3.

Switching from brand-name to generic psychotropic medications: a literature review.

Desmarais JE, Beauclair L, Margolese HC.

CNS Neurosci Ther. 2011 Dec;17(6):750-60. doi: 10.1111/j.1755-5949.2010.00210.x. Epub 2010 Nov 30. Review.

PMID:
21114789
[PubMed - indexed for MEDLINE]
4.

Potential concerns about generic substitution: bioequivalence versus therapeutic equivalence of different amlodipine salt forms.

Meredith PA.

Curr Med Res Opin. 2009 Sep;25(9):2179-89. doi: 10.1185/03007990903116867. Review.

PMID:
19601710
[PubMed - indexed for MEDLINE]
5.

Loss of response after switching from brand name to generic formulations: three cases and a discussion of key clinical considerations when switching.

Margolese HC, Wolf Y, Desmarais JE, Beauclair L.

Int Clin Psychopharmacol. 2010 May;25(3):180-2. doi: 10.1097/YIC.0b013e328337910b.

PMID:
20216221
[PubMed - indexed for MEDLINE]
6.

Recommendations of the Italian League against Epilepsy working group on generic products of antiepileptic drugs.

Perucca E, Albani F, Capovilla G, Bernardina BD, Michelucci R, Zaccara G.

Epilepsia. 2006;47 Suppl 5:16-20.

PMID:
17239100
[PubMed - indexed for MEDLINE]
7.

Generic versus brand name drugs in psychopharmacology: a pharmacoeconomic perspective.

Emanuele E.

South Med J. 2011 Oct;104(10):715-6. doi: 10.1097/SMJ.0b013e31822cf201. No abstract available.

PMID:
21941163
[PubMed - indexed for MEDLINE]
8.

Generic immunosuppression in solid organ transplantation: a Canadian perspective.

Harrison JJ, Schiff JR, Coursol CJ, Daley CJ, Dipchand AI, Heywood NM, Keough-Ryan TM, Keown PA, Levy GA, Lien DC, Wichart JR, Cantarovich M.

Transplantation. 2012 Apr 15;93(7):657-65. doi: 10.1097/TP.0b013e3182445e9d. Review.

PMID:
22267158
[PubMed - indexed for MEDLINE]
9.

Generic and therapeutic statin switches and disruptions in therapy.

Chapman RH, Benner JS, Girase P, Benigno M, Axelsen K, Liu LZ, Nichol MB.

Curr Med Res Opin. 2009 May;25(5):1247-60. doi: 10.1185/03007990902876271 .

PMID:
19344292
[PubMed - indexed for MEDLINE]
10.

Brand name versus generic warfarin: a systematic review of the literature.

Dentali F, Donadini MP, Clark N, Crowther MA, Garcia D, Hylek E, Witt DM, Ageno W; Warfarin Associated Research Projects and Other Endeavors (WARPED) Consortium.

Pharmacotherapy. 2011 Apr;31(4):386-93. doi: 10.1592/phco.31.4.386. Review.

PMID:
21449627
[PubMed - indexed for MEDLINE]
11.

Generic products of antiepileptic drugs: a perspective on bioequivalence, bioavailability, and formulation switches using Monte Carlo simulations.

Karalis V, Macheras P, Bialer M.

CNS Drugs. 2014 Jan;28(1):69-77. doi: 10.1007/s40263-013-0112-8.

PMID:
24092569
[PubMed - indexed for MEDLINE]
12.

[Bioequivalence and generics of index drugs with narrow therapeutic margins].

Le Corre P.

Presse Med. 2010 Feb;39(2):169-76. doi: 10.1016/j.lpm.2009.09.017. Epub 2009 Nov 22. French.

PMID:
19932591
[PubMed - indexed for MEDLINE]
13.

Challenges of therapeutic substitution of drugs for economic reasons: focus on CVD prevention.

Johnston A.

Curr Med Res Opin. 2010 Apr;26(4):871-8. doi: 10.1185/03007990903578462.

PMID:
20144139
[PubMed - indexed for MEDLINE]
14.

Evaluating the bioavailability and bioequivalence of generic medications.

Howland RH.

J Psychosoc Nurs Ment Health Serv. 2010 Jan;48(1):13-6. doi: 10.3928/02793695-20091204-07.

PMID:
20102127
[PubMed - indexed for MEDLINE]
15.

When is a "generic" medication not really a generic?

Howland RH.

J Psychosoc Nurs Ment Health Serv. 2010 Feb;48(2):13-6. doi: 10.3928/02793695-20100108-98.

PMID:
20166651
[PubMed - indexed for MEDLINE]
16.

Drug substitution in transplantation: a National Kidney Foundation White Paper.

Sabatini S, Ferguson RM, Helderman JH, Hull AR, Kirkpatrick BS, Barr WH.

Am J Kidney Dis. 1999 Feb;33(2):389-97. Review.

PMID:
10023656
[PubMed - indexed for MEDLINE]
17.

Understanding therapeutic equivalence in epilepsy.

Sankar R, Glauser TA.

CNS Spectr. 2010 Feb;15(2):112-23. Review.

PMID:
20414156
[PubMed - indexed for MEDLINE]
18.

Generic products of antiepileptic drugs: a perspective on bioequivalence and interchangeability.

Bialer M, Midha KK.

Epilepsia. 2010 Jun;51(6):941-50. doi: 10.1111/j.1528-1167.2010.02573.x. Epub 2010 Apr 8. Review.

PMID:
20384761
[PubMed - indexed for MEDLINE]
19.

Symptom relapse following switch from Celexa to generic citalopram: an anxiety disorders case series.

Van Ameringen M, Mancini C, Patterson B, Bennett M.

J Psychopharmacol. 2007 Jul;21(5):472-6.

PMID:
17664246
[PubMed - indexed for MEDLINE]
20.

Lack of pharmacokinetic bioequivalence between generic and branded amoxicillin formulations. A post-marketing clinical study on healthy volunteers.

Del Tacca M, Pasqualetti G, Di Paolo A, Virdis A, Massimetti G, Gori G, Versari D, Taddei S, Blandizzi C.

Br J Clin Pharmacol. 2009 Jul;68(1):34-42. doi: 10.1111/j.1365-2125.2009.03399.x.

PMID:
19660001
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk